Publication
Bioprospection of the antarctic diatoms craspedostauros ineffabilis IMA082A and Craspedostauros zucchelli IMA088A
dc.contributor.author | Trentin, Riccardo | |
dc.contributor.author | Moschin, Emanuela | |
dc.contributor.author | L, Custódio | |
dc.contributor.author | Moro, Isabella | |
dc.date.accessioned | 2024-01-30T13:48:11Z | |
dc.date.available | 2024-01-30T13:48:11Z | |
dc.date.issued | 2024-01-06 | |
dc.date.updated | 2024-01-26T14:10:44Z | |
dc.description.abstract | In extreme environments such as Antarctica, a diverse range of organisms, including diatoms, serve as essential reservoirs of distinctive bioactive compounds with significant implications in pharmaceutical, cosmeceutical, nutraceutical, and biotechnological fields. This is the case of the new species Craspedostauros ineffabilis IMA082A and Craspedostauros zucchellii IMA088A Trentin, Moschin, Lopes, Custódio and Moro (Bacillariophyta) that are here explored for the first time for possible biotechnological applications. For this purpose, a bioprospection approach was applied by preparing organic extracts (acetone and methanol) from freeze-dried biomass followed by the evaluation of their in vitro antioxidant properties and inhibitory activities on enzymes related with Alzheimer’s disease (acetylcholinesterase: AChE, butyrylcholinesterase: BChE), Type 2 diabetes mellitus (T2DM, α–glucosidase, α–amylase), obesity (lipase) and hyperpigmentation (tyrosinase). Extracts were then profiled by ultra-high-performance liquid chromatography–mass spectrometry (UPLC–HR–MS/MS), while the fatty acid methyl ester (FAME) profiles were established by gas chromatography–mass spectrometry (GC–MS). Our results highlighted strong copper chelating activity of the acetone extract from C. ineffabilis and moderate to high inhibitory activities on AChE, BChE, α–amylase and lipase for extracts from both species. The results of the chemical analysis indicated polyunsaturated fatty acids (PUFA) and their derivatives as the possible compounds responsible for the observed activities. The FAME profile showed saturated fatty acids (SFA) as the main group and methyl palmitoleate (C16:1) as the predominant FAME in both species. Overall, our results suggest both Antarctic strains as potential sources of interesting molecules with industrial applications. Further studies aiming to investigate unidentified metabolites and to maximize growth yield and natural compound production are required. | pt_PT |
dc.description.sponsorship | Programs CRESC Algarve 2020 and COMPETE 2020 through project EMBRC.PT ALG-01-0145-FEDER-022121. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Marine Drugs 22 (1): 35 (2024) | pt_PT |
dc.identifier.doi | 10.3390/md22010035 | pt_PT |
dc.identifier.eissn | 1660-3397 | |
dc.identifier.uri | http://hdl.handle.net/10400.1/20325 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | MDPI | pt_PT |
dc.relation | Algarve Centre for Marine Sciences | |
dc.relation | Algarve Centre for Marine Sciences | |
dc.relation | Centre for Marine and Environmental Research | |
dc.relation | Not Available | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | Antarctica | pt_PT |
dc.subject | Biological activity | pt_PT |
dc.subject | Antioxidant activity | pt_PT |
dc.subject | PUFAs | pt_PT |
dc.subject | Blue biotechnology | pt_PT |
dc.subject | Extreme environments | pt_PT |
dc.title | Bioprospection of the antarctic diatoms craspedostauros ineffabilis IMA082A and Craspedostauros zucchelli IMA088A | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardTitle | Algarve Centre for Marine Sciences | |
oaire.awardTitle | Algarve Centre for Marine Sciences | |
oaire.awardTitle | Centre for Marine and Environmental Research | |
oaire.awardTitle | Not Available | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04326%2F2020/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04326%2F2020/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/LA%2FP%2F0101%2F2020/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/CEEC IND 2017/CEECIND%2F00425%2F2017%2FCP1391%2FCT0001/PT | |
oaire.citation.issue | 1 | pt_PT |
oaire.citation.startPage | 35 | pt_PT |
oaire.citation.title | Marine Drugs | pt_PT |
oaire.citation.volume | 22 | pt_PT |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | CEEC IND 2017 | |
person.familyName | Custódio | |
person.givenName | Luísa | |
person.identifier.ciencia-id | 791B-C560-AEA2 | |
person.identifier.orcid | 0000-0003-4338-7703 | |
person.identifier.rid | M-6101-2013 | |
person.identifier.scopus-author-id | 15831018900 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | f9cfed0f-6b67-413e-988c-ac7397183471 | |
relation.isAuthorOfPublication.latestForDiscovery | f9cfed0f-6b67-413e-988c-ac7397183471 | |
relation.isProjectOfPublication | fafa76a6-2cd2-4a6d-a3c9-772f34d3b91f | |
relation.isProjectOfPublication | 15f91d45-e070-47d8-b6b8-efd4de31d9a8 | |
relation.isProjectOfPublication | 794d4c77-c731-471e-bc96-5a41dcd3d872 | |
relation.isProjectOfPublication | 6c0c2a76-3a99-4e0a-94d2-e023eaf0d5f4 | |
relation.isProjectOfPublication.latestForDiscovery | 794d4c77-c731-471e-bc96-5a41dcd3d872 |